Reinhart Partners Portfolio holdings
Top Buys
| 1 |
IAA
IAA, Inc. Common Stock
IAA
|
+$28.5M |
| 2 |
Assured Guaranty
AGO
|
+$14M |
| 3 |
Charles River Laboratories
CRL
|
+$10.1M |
| 4 |
Gentex
GNTX
|
+$9.78M |
| 5 |
Fidelity National Financial
FNF
|
+$5.92M |
Top Sells
| 1 |
EVOP
EVO Payments, Inc. Class A Common Stock
EVOP
|
+$29.6M |
| 2 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
+$24.4M |
| 3 |
ACC
American Campus Communities, Inc.
ACC
|
+$23.6M |
| 4 |
Encompass Health
EHC
|
+$16.3M |
| 5 |
AdaptHealth
AHCO
|
+$15.8M |
Sector Composition
| 1 | Financials | 24.62% |
| 2 | Industrials | 24.3% |
| 3 | Consumer Discretionary | 10.49% |
| 4 | Technology | 10.27% |
| 5 | Real Estate | 9.58% |
Similar funds
Reinhart Partners's Q3 2022 Portfolio in Review
As of Q3 2022, Reinhart Partners held 82 positions worth $1.62B, down 11% from $1.82B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Reinhart Partners withdrew a net $92.7M in Q3 2022, closing 5 positions and reducing 49 holdings. Its most notable exit was EVO Payments, Inc. Class A Common Stock, an estimated $29.6M position sold in full.
By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 21% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Reinhart Partners opened a new position in IAA, Inc. Common Stock worth $25.6M.
- Reinhart Partners's largest Q3 2022 buy was IAA, Inc. Common Stock: 802,245 shares worth $25.6M.
- Reinhart Partners added most to Assured Guaranty in Q3 2022, an estimated $14M increase.
- Reinhart Partners's biggest Q3 2022 reduction was Change Healthcare Inc. Common Stock, cutting an estimated $24.4M.
- Reinhart Partners fully exited EVO Payments, Inc. Class A Common Stock in Q3 2022, selling an estimated $29.6M.
- Reinhart Partners's ten largest holdings make up 28% of its $1.62B portfolio in Q3 2022.
- Reinhart Partners opened 3 new positions and closed 5 in Q3 2022.
- Reinhart Partners's portfolio value fell 11% quarter-over-quarter to $1.62B.
Based on Reinhart Partners's 13F filing for Q3 2022, filed 1 Nov 2022.